Selumetinib in Combination With Dacarbazine in Patients With Metastatic Uveal Melanoma: A Phase III, Multicenter, Randomized Trial (SUMIT). (Q52660928)
Jump to navigation
Jump to search
scientific article published on 12 March 2018
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Selumetinib in Combination With Dacarbazine in Patients With Metastatic Uveal Melanoma: A Phase III, Multicenter, Randomized Trial (SUMIT). |
scientific article published on 12 March 2018 |
Statements
Selumetinib in Combination With Dacarbazine in Patients With Metastatic Uveal Melanoma: A Phase III, Multicenter, Randomized Trial (SUMIT). (English)
1 reference
Jacob Schachter
1 reference
Richard D Carvajal
1 reference
Sophie Piperno-Neumann
1 reference
Paul B Chapman
1 reference
Stephen Frank
1 reference
Pascal Wolter
1 reference
Veronique Cocquyt
1 reference
Bartosz Chmielowski
1 reference
T R Jeffry Evans
1 reference
Lauris Gastaud
1 reference
Gerald Linette
1 reference
Carola Berking
1 reference
Manuel J Rodrigues
1 reference
Alexander N Shoushtari
1 reference
Delyth Clemett
1 reference
Dana Ghiorghiu
1 reference
Gabriella Mariani
1 reference
Shirley Spratt
1 reference
Susan Lovick
1 reference
Peter Barker
1 reference
Elaine Kilgour
1 reference
Zhongwu Lai
1 reference
Gary K Schwartz
1 reference
Paul Nathan
1 reference
12 March 2018
1 reference
36
1 reference
1232-1239
1 reference
12
1 reference